The economics of male birth control

A history of male contraceptive development – as experienced and related by our founder Elaine Lissner – was recently covered in a Priceonomics article called “The Economics of Male Birth Control“. Written by Rosie Cima, the article chronicles the life’s work of Ms. Lissner who spent decades advocating for and supporting the development of new male contraceptive options. It may be surprising to most readers to find that scientific advancement has not held up the progress toward new male reproductive control technologies. Instead, economic pressures such as funding, liability and marketing are the culprits. You won’t want to miss reading this insightful and interesting article!

Tell us what you think

This form does not collect your email address. If you would like us to respond, please send questions to
This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today